| P2093 | author name string | Jacques Bernier | |
| P2860 | cites work | Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. | Q65000521 |
| | Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy | Q67984672 |
| | Adjuvant chemotherapy in head and neck cancer | Q68417268 |
| | The hazard of accelerated tumor clonogen repopulation during radiotherapy | Q68431535 |
| | Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Long-term results of the Radiation Therapy Oncology Group study 81-17 | Q68578843 |
| | Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials | Q71059702 |
| | Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial | Q73589822 |
| | Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial | Q73677933 |
| | A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer | Q73677937 |
| | Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer | Q74668378 |
| | Concomitant chemotherapy and radiation therapy certainly improves local control | Q81224010 |
| | Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. | Q30591228 |
| | Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis | Q34278528 |
| | The mechanism of action of radiosensitization of conventional chemotherapeutic agents | Q35042078 |
| | Altered fractionation and/or adjuvant chemotherapy in definitive irradiation of squamous cell carcinoma of the head and neck | Q35077559 |
| | Altered fractionation and combined radio-chemotherapy approaches: pioneering new opportunities in head and neck oncology. | Q35082353 |
| | Toxicity profile of intensity-modulated radiation therapy for head and neck carcinoma and potential role of amifostine | Q35630915 |
| | Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors | Q37919766 |
| | An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer | Q41939496 |
| | Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy--results of a multicentric randomized German trial in advanced head-and-neck cancer. | Q43694213 |
| | Concomitant chemotherapy-radiation therapy followed by hyperfractionated radiation therapy for advanced unresectable head and neck cancer. | Q43816613 |
| | An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer | Q44265661 |
| | Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer | Q44276678 |
| | Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study | Q44661695 |
| | Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers | Q44953696 |
| | Tirapazamine, Cisplatin, and Radiation versus Fluorouracil, Cisplatin, and Radiation in patients with locally advanced head and neck cancer: a randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02). | Q45206507 |
| | A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck | Q45236091 |
| | Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiothera | Q45271712 |
| | Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trial | Q46910682 |
| | Primary radiotherapy of squamous cell carcinoma of the oropharynx and pharyngolarynx: Tentative multivariate modelling system to predict the radiocurability of neck nodes | Q52426866 |
| | Altered fractionation trials in head and neck cancer | Q56060727 |
| | Concomitant Cisplatin Significantly Improves Locoregional Control in Advanced Head and Neck Cancers Treated With Hyperfractionated Radiotherapy | Q61810997 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adaptive radiation therapy | Q180507 |
| | chemotherapy | Q974135 |
| P304 | page(s) | 305-314 | |
| P577 | publication date | 2005-06-01 | |
| P1433 | published in | Nature Clinical Practice Oncology | Q15752073 |
| P1476 | title | Alteration of radiotherapy fractionation and concurrent chemotherapy: a new frontier in head and neck oncology? | |
| P478 | volume | 2 | |